×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
0
Days
0
Hours
0
Minutes
0
Seconds


Monday, September 22nd 2025
01pm to 01:45pm (GMT+2)

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
Add to calendar Notify me
 Browser notifications are enabled

Intervenants :

 

Pr Jean-Sébastien Frenel

Dr Frédéric Selle

 

Programme :

 

- Présentation des recommandations sur la maintenance, avec un focus sur le choix des différents niveaux de preuve.

- Pourquoi avoir choisi de partir des contre-indications au BEV qui fait l'originalité de ces recommandations comparées à ASCO/ESMO ?

- Quelle maintenance CC0 vs non-CC0, pN+, notion de haut risque vs bas risque, pour qui le BEV ?

- Débat/Discussion & Réponses aux questions

 

Shooting date : 2025-09-22
Last update : 2025-08-20
Jean-Sébastien Frenel
Saint-Herblain, France
Oncology
Frédéric Selle
Paris, France
Oncology

Suggestions

Tuesday, September 10th 2024 from 06pm to 07:30pm (GMT+2)
Honolulu : Tuesday, September 10th 2024 from 06am to 07:30am (GMT+2)
San Francisco : Tuesday, September 10th 2024 from 09am to 10:30am (GMT+2)
New York : Tuesday, September 10th 2024 from 12pm to 01:30pm (GMT+2)
Buenos Aires : Tuesday, September 10th 2024 from 01pm to 02:30pm (GMT+2)
Reykjavik : Tuesday, September 10th 2024 from 04pm to 05:30pm (GMT+2)
London / Dublin : Tuesday, September 10th 2024 from 05pm to 06:30pm (GMT+2)
Paris / Berlin : Tuesday, September 10th 2024 from 06pm to 07:30pm (GMT+2)
Istanbul : Tuesday, September 10th 2024 from 07pm to 08:30pm (GMT+2)
Moscou / Dubaï : Tuesday, September 10th 2024 from 08pm to 09:30pm (GMT+2)
Bangkok : Tuesday, September 10th 2024 from 11pm to 12:30am (GMT+2)
Shanghai : Wednesday, September 11th 2024 from 12am to 01:30am (GMT+2)
Tokyo : Wednesday, September 11th 2024 from 01am to 02:30am (GMT+2)
Sydney : Wednesday, September 11th 2024 from 03am to 04:30am (GMT+2)
Wellington : Wednesday, September 11th 2024 from 05am to 06:30am (GMT+2)

iPARP et cancer de l’ovaire : quand et pour qui ?

Share
Wednesday, March 26th 2025 from 01pm to 01:45pm (GMT+1)
Honolulu : Wednesday, March 26th 2025 from 01am to 01:45am (GMT+1)
San Francisco : Wednesday, March 26th 2025 from 03am to 03:45am (GMT+1)
New York : Wednesday, March 26th 2025 from 06am to 06:45am (GMT+1)
Buenos Aires : Wednesday, March 26th 2025 from 08am to 08:45am (GMT+1)
London / Dublin : Wednesday, March 26th 2025 from 11am to 11:45am (GMT+1)
Paris / Berlin : Wednesday, March 26th 2025 from 12pm to 12:45pm (GMT+1)
Istanbul : Wednesday, March 26th 2025 from 01pm to 01:45pm (GMT+1)
Moscou / Dubaï : Wednesday, March 26th 2025 from 03pm to 03:45pm (GMT+1)
Bangkok : Wednesday, March 26th 2025 from 06pm to 06:45pm (GMT+1)
Shanghai : Wednesday, March 26th 2025 from 07pm to 07:45pm (GMT+1)
Tokyo : Wednesday, March 26th 2025 from 08pm to 08:45pm (GMT+1)
Sydney : Wednesday, March 26th 2025 from 09pm to 09:45pm (GMT+1)
Wellington : Wednesday, March 26th 2025 from 11pm to 11:45pm (GMT+1)

Comment prendre en charge un cancer de l'endomètre avancé ?

Cancer de l’endomètre avancé en rechute précoce : que proposer en 2025 ? (épisode 2)

Share
Tuesday, November 21st 2023 from 06pm to 07:30pm (GMT+1)
Honolulu : Tuesday, November 21st 2023 from 06am to 07:30am (GMT+1)
San Francisco : Tuesday, November 21st 2023 from 08am to 09:30am (GMT+1)
New York : Tuesday, November 21st 2023 from 11am to 12:30pm (GMT+1)
Buenos Aires : Tuesday, November 21st 2023 from 01pm to 02:30pm (GMT+1)
London / Dublin : Tuesday, November 21st 2023 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Tuesday, November 21st 2023 from 05pm to 06:30pm (GMT+1)
Istanbul : Tuesday, November 21st 2023 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Tuesday, November 21st 2023 from 08pm to 09:30pm (GMT+1)
Bangkok : Tuesday, November 21st 2023 from 11pm to 12:30am (GMT+1)
Shanghai : Wednesday, November 22nd 2023 from 12am to 01:30am (GMT+1)
Tokyo : Wednesday, November 22nd 2023 from 01am to 02:30am (GMT+1)
Sydney : Wednesday, November 22nd 2023 from 02am to 03:30am (GMT+1)
Wellington : Wednesday, November 22nd 2023 from 04am to 05:30am (GMT+1)

Cancer de l'ovaire : comment évaluer aujourd'hui la recombinaison homologue ?

Share
Wednesday, February 7th 2024 from 06pm to 07:30pm (GMT+1)
Honolulu : Wednesday, February 7th 2024 from 06am to 07:30am (GMT+1)
San Francisco : Wednesday, February 7th 2024 from 08am to 09:30am (GMT+1)
New York : Wednesday, February 7th 2024 from 11am to 12:30pm (GMT+1)
Buenos Aires : Wednesday, February 7th 2024 from 01pm to 02:30pm (GMT+1)
London / Dublin : Wednesday, February 7th 2024 from 04pm to 05:30pm (GMT+1)
Paris / Berlin : Wednesday, February 7th 2024 from 05pm to 06:30pm (GMT+1)
Istanbul : Wednesday, February 7th 2024 from 06pm to 07:30pm (GMT+1)
Moscou / Dubaï : Wednesday, February 7th 2024 from 08pm to 09:30pm (GMT+1)
Bangkok : Wednesday, February 7th 2024 from 11pm to 12:30am (GMT+1)
Shanghai : Thursday, February 8th 2024 from 12am to 01:30am (GMT+1)
Tokyo : Thursday, February 8th 2024 from 01am to 02:30am (GMT+1)
Sydney : Thursday, February 8th 2024 from 02am to 03:30am (GMT+1)
Wellington : Thursday, February 8th 2024 from 04am to 05:30am (GMT+1)

Toxicités hématologiques des inhibiteurs de PARP

Regards croisés oncologue-hématologue-interniste

Share
Scroll Up